[Evaluation of latent changes in blood coagulation by the determination of plasma thrombin-antithrombin complex in gastrointestinal neoplasms].

Abstract

The relationship between cancer and coagulation disorders is widely accepted. Such disorders can contribute to the metastatic spreading of the primary tumor. Aim of our study was to evaluate the alterations of thrombin-antithrombin III complex (TAT) measured by an ELISA plasma assay in a population of 78 patients suffering from various gastrointestinal tumors. We found high levels of TAT in 68.6% of the patients. Our data show that assay of TAT plasma levels may be a useful test in detecting early coagulation disorders in cancer patients.

• Authors: L Guidi, C Bartoloni, P Pellicanò, A Cappelli, F Cursi, R Pili, A Tricerri, F Patriarca, G Gambassi
• Journal: La Clinica terapeutica (Clin Ter) Vol. 136 Issue 6 Pg. 367-73 (Mar 31 1991) ISSN: 0009-9074 [Print] Italy
• Vernacular Title: Valutazione di alterazioni latenti della coagulazione mediante il dosaggio plasmatico del complesso trombina antitrombina nelle neoplasie gastrointestinali.
• PMID: 1828201 (Publication Type: Comparative Study, English Abstract, Journal Article)

Chemical References

• Biomarkers, Tumor
• antithrombin III-protease complex
• Antithrombin III
• Peptide Hydrolases

Topics

• Antithrombin III (analysis)
• Biliary Tract Neoplasms (blood, diagnosis)
• Biomarkers, Tumor
• Blood Coagulation Disorders (diagnosis)
• Colonic Neoplasms (blood, diagnosis)
• Diagnosis, Differential
• Enzyme-Linked Immunosorbent Assay
• Gastrointestinal Neoplasms (blood, diagnosis)
• Humans
• Liver Neoplasms (blood, diagnosis)
• Pancreatic Neoplasms (blood, diagnosis)
• Peptide Hydrolases (analysis)
• Stomach Neoplasms (blood, diagnosis)